Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study.

Viviana FrantellizziFabio MonariManlio MasciaRenato CostaGiuseppe RubiniAngela SpanuArianna Di RoccoElisa Lodi RizziniLuca CindoloMaria LicariValentina LavelliSusanna NuvoliCristina De AngelisValeria DionisiCristina FerrariGiuseppe De Vincentis

Published in: Annals of nuclear medicine (2020)

This study confirms the validity of the 3-PS score for mCRPC patients. This score is simple, noninvasive and affordable and can be easily used to select patients that will most probably complete 223Ra treatment. In addition, this tool provides an exact estimate of life expectancy in terms of OS.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
rheumatoid arthritis
quality improvement
molecular dynamics
patient reported
systemic lupus erythematosus